相关实验视频
Updated: Jul 17, 2025

08:23
CIRCLE-Seq for Interrogation of Off-Target Gene Editing
Published on: November 1, 2024
680
危险分析:在没有参考基因组的情况下对CRISPR编辑进行风险偏向的目标/非目标评估
Kazuki Nakamae1,2, Hidemasa Bono1,3
1Laboratory of Bio-DX, Genome Editing Innovation Center, Hiroshima University, 3-10-23 Kagamiyama, Higashi-Hiroshima, Hiroshima 739-0046, Japan.
Bioinformatics advances
|September 4, 2023
概括
这项研究引入了DANGER分析,这是一个新的生物信息学管道,用于评估CRISPR基因编辑安全性. 它使用RNA-seq数据量化了对表型的潜在非目标效应,从而实现了更安全的基因组编辑设计.
科学领域:
- 基因组学和生物信息学
- 分子生物学分子生物学
- 基因编辑技术的技术
背景情况:
- 克里斯普尔-Cas9可实现精确的基因编辑,但可能会导致影响表型的意外非目标突变.
- 传统研究往往忽视了有害的目标外效应对观察到的基因编辑结果的影响.
- 需要一个强大的方法来评估目标和非目标效应,以便进行准确的表型分析.
研究的目的:
- 引入一个新的生物信息学管道,通过RNA测序 (DANGER) 分析评估的有害和可预期指南.
- 为了能够对与CRISPR介导的基因编辑相关的表型风险进行定量评估,包括非目标效应.
- 为了促进在各种生物体中更安全的基因组编辑设计.
主要方法:
- 利用RNA测序 (RNA-seq) 数据来识别影响mRNA表达的基因组在/离目标部位的基因组.
- 开发了一个生物信息学管道,以在基因本体学 (GO) 术语层面量化表型风险.
- 使用 de novo 转录组组件进行基因组编辑评估,而不需要参考基因组.
主要成果:
- 在基因编辑的人类细胞和斑马鱼大脑的RNA-seq数据中,DANGER分析成功检测出异位位点.
- 该管道量化评估了有害的目标外物对编辑突变物中转录组表型的贡献.
- 经过证明的风险对冲在/离目标评估能力,即使在没有参考基因组的情况下.
结论:
- 危险分析提供了一种可靠的方法来评估CRISPR基因编辑的安全性和潜在的表型后果.
- 该管道适用于广泛的生物体,包括非模型物种,人类基因组和病毒/疾病基因组.
- 促进设计更安全,更可靠的基因组编辑策略,用于研究和治疗应用.
相关概念视频
CRISPR/Cas9 Genome Editing
49
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
49
CRISPR
52.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.3K
CRISPR and crRNAs
17.1K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.1K
Homologous Recombination
50.6K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.6K

